Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
All Products (882)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Anidulafungin |
Antifungal (Febrile Neutropenia) | Both (Solid & Hematologic) | ||
|
Molecule
Anidulafungin
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antifungal (Febrile Neutropenia) |
||||
Annamycin |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Annamycin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Anti-Inhibitor Coagulant Complex |
Hematinic / Clotting Factor / Plasma Product | Hematologic | ||
|
Molecule
Anti-Inhibitor Coagulant Complex
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
||||
Apaziquone |
Alkylating Agent | Both (Solid & Hematologic) | ||
|
Molecule
Apaziquone
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
||||
Apixaban |
Anticoagulant (Cancer-Associated Thrombosis) | Both (Solid & Hematologic) | ||
|
Molecule
Apixaban
Therapeutic Category
Supportive Care (Anticoagulant)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anticoagulant (Cancer-Associated Thrombosis) |
||||
Aprepitant |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Aprepitant
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Arsenic Trioxide |
Retinoid / Arsenical | Hematologic (APL) / Solid Tumour | ||
|
Molecule
Arsenic Trioxide
Therapeutic Category
Differentiating Agent
Oncology Type
Hematologic (APL) / Solid Tumour
Drug Class / Mechanism
Retinoid / Arsenical |
||||
Asparaginase Erwinia Chrysanthemi (Crisantaspase) |
Enzyme / Oncolytic Virus / Miscellaneous Cytotoxic | Both (Solid & Hematologic) | ||
|
Molecule
Asparaginase Erwinia Chrysanthemi (Crisantaspase)
Therapeutic Category
Cytotoxic Chemotherapy / Miscellaneous
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Enzyme / Oncolytic Virus / Miscellaneous Cytotoxic |
||||
Atovaquone (PJP Prophylaxis) |
Antiviral / Antiprotozoal Prophylaxis | Both (Solid & Hematologic) | ||
|
Molecule
Atovaquone (PJP Prophylaxis)
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antiviral / Antiprotozoal Prophylaxis |
||||
Avatrombopag |
Thrombopoietin Receptor Agonist | Hematologic (Thrombocytopenia) | ||
|
Molecule
Avatrombopag
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Hematologic (Thrombocytopenia)
Drug Class / Mechanism
Thrombopoietin Receptor Agonist |
||||
Azacitidine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Azacitidine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Azasetron |
5-HT3 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Azasetron
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
||||
AnidulafunginSupportive Care (Anti-Infective) |
|
|
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antifungal (Febrile Neutropenia) |
|
AnnamycinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
Anti-Inhibitor Coagulant ComplexSupportive Care (Hematinic / Coagulation Factor) |
|
|
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
|
ApaziquoneCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
|
ApixabanSupportive Care (Anticoagulant) |
|
|
Therapeutic Category
Supportive Care (Anticoagulant)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anticoagulant (Cancer-Associated Thrombosis) |
|
AprepitantSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|
Arsenic TrioxideDifferentiating Agent |
|
|
Therapeutic Category
Differentiating Agent
Oncology Type
Hematologic (APL) / Solid Tumour
Drug Class / Mechanism
Retinoid / Arsenical |
|
Asparaginase Erwinia Chrysanthemi (Crisantaspase)Cytotoxic Chemotherapy / Miscellaneous |
|
|
Therapeutic Category
Cytotoxic Chemotherapy / Miscellaneous
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Enzyme / Oncolytic Virus / Miscellaneous Cytotoxic |
|
Atovaquone (PJP Prophylaxis)Supportive Care (Anti-Infective) |
|
|
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antiviral / Antiprotozoal Prophylaxis |
|
AvatrombopagSupportive Care (Growth Factor) |
|
|
Therapeutic Category
Supportive Care (Growth Factor)
Oncology Type
Hematologic (Thrombocytopenia)
Drug Class / Mechanism
Thrombopoietin Receptor Agonist |
|
AzacitidineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
AzasetronSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
|